Skip to main content

Table 3 Adverse events expected when taking salbutamol, taken from the SmPC

From: How can we optimise inhaled beta2 agonist dose as ‘reliever’ medicine for wheezy pre-school children? Study protocol for a randomised controlled trial

Adverse event

Common

Uncommon

Rare

Very rare

Immune system disorders

 

Hypersensitivity reactions (angio-oedema, urticaria, hypotension and collapse)

  

Metabolism and nutrition disorders

  

Hypokalaemia

 

Nervous system disorders

 

Headache

Hyperactivity, restlessness, dizziness

 

Cardiac disorders

Palpitations

  

Myocardial ischaemia, cardiac arrhythmias including atrial fibrilation, supraventricular tachycardia and extrasystoles

Vascular disorders

Peripheral vasodilatation, and as a result small increase in heart rate

   

Respiratory, thoracic and mediastinal disorders

  

Bronchospasm, cough, irritation of mouth and throat which may be prevented by rinsing the mouth after inhalation

 

Musculoskeletal and connective tissue and bone disorders

Tremor

 

Muscle cramps